陸氏集團(越南)(00366.HK)2021年淨利8466.9萬港元 同比上升約37.6%
格隆匯3月25日丨陸氏集團(越南)(00366.HK)公吿,截至2021年12月31日止年度,集團營業額為港幣5.13億元,同比下跌約2.9%。股東應占綜合淨溢利8466.9萬港元,同比上升約37.6%。每股基溢利港幣16.8仙(2020年:港幣12.2仙)。
由於香港政府實施嚴格對外入境限制與及隔離措施,訪港旅客大幅減少,但集團位於香港的"香港屯門貝爾特酒店"改變策略吸引香港本地居民入住,成功令集團酒店業務,在扣除酒店物業折舊前,由去年的虧損,轉為2021年錄得的盈利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.